Literature DB >> 29030419

Accuracy of clinical diagnosis of dementia with Lewy bodies: a systematic review and meta-analysis.

Giovanni Rizzo1,2, Simona Arcuti3,4, Massimiliano Copetti4, Maria Alessandria3, Rodolfo Savica5, Andrea Fontana4, Rocco Liguori1,2, Giancarlo Logroscino3,6.   

Abstract

BACKGROUND: The diagnosis of dementia with Lewy bodies (DLB) is based on diagnostic clinical criteria, which were updated over the years.
OBJECTIVE: To evaluate, through a systematic review, accuracy of the diagnostic criteria, testing a possible improvement over time.
METHODS: We searched on MEDLINE and SCOPUS databases for studies reporting diagnostic parameters regarding the clinical diagnosis of DLB until October 2016. We performed meta-analysis, using a Bayesian approach, on those using pathological examination as gold standard, subclassified based on the different diagnostic criteria used.
RESULTS: We selected 22 studies on 1585 patients. Pooled sensitivity, specificity and accuracy were 60.2%, 93.8%, 79.7%, respectively, for criteria antecedents to McKeith 1996. For McKeith 1996-possible, pooled sensitivity, specificity and accuracy were 65.6%, 80.6%, 77.9% in early stages and 72.3%, 64.3%, 66% in late stages, respectively. For McKeith 1996-probable, pooled sensitivity, specificity and accuracy were 19.4%, 95.1%, 77.7% in early stages and 48.6%, 88%, 79.2% in late stages, respectively. McKeith criteria 2005 were evaluated only in late stages: pooled sensitivity, specificity and accuracy were 91.3%, 66.7% and 81.6%, respectively, for possible diagnosis (only one study) and 88.3%, 80.8%, 90.7% for probable diagnosis, decreasing to 85.6%, 77.1% and 81.7% if only considering clinical settings focused on dementia diagnosis and care. CONCLUSIONS AND RELEVANCE: Diagnostic criteria have become more sensitive and less specific over time, without substantial change in the accuracy. Based on current data, about 20% of DLB diagnosis are incorrect. Future studies are needed to evaluate if the recently released revised consensus criteria will improve the diagnostic accuracy of DLB. © Article author(s) (or their employer(s) unless otherwise stated in the text of the article) 2018. All rights reserved. No commercial use is permitted unless otherwise expressly granted.

Entities:  

Keywords:  clinical neurology; lewy body dementia; meta-analysis; systematic reviews

Mesh:

Year:  2017        PMID: 29030419     DOI: 10.1136/jnnp-2017-316844

Source DB:  PubMed          Journal:  J Neurol Neurosurg Psychiatry        ISSN: 0022-3050            Impact factor:   10.154


  36 in total

Review 1.  Skin nerve α-synuclein deposits in Parkinson's disease and other synucleinopathies: a review.

Authors:  Vincenzo Donadio
Journal:  Clin Auton Res       Date:  2018-11-30       Impact factor: 4.435

Review 2.  Biomarkers for neurodegenerative diseases.

Authors:  Oskar Hansson
Journal:  Nat Med       Date:  2021-06-03       Impact factor: 53.440

Review 3.  Dementia with Lewy bodies and Parkinson's disease-dementia: current concepts and controversies.

Authors:  Kurt A Jellinger
Journal:  J Neural Transm (Vienna)       Date:  2017-12-08       Impact factor: 3.575

4.  LeSCoD: a new clinical scale for the detection of Lewy body disease in neurocognitive disorders.

Authors:  Pauline Olivieri; Thibaud Lebouvier; Jean-Benoît Hardouin; Hélène Courtemanche; Séverine Le Dily; Laëtitia Barbin; Amandine Pallardy; Pascal Derkinderen; Claire Boutoleau-Bretonnière
Journal:  J Neurol       Date:  2021-04-08       Impact factor: 4.849

Review 5.  Neuropathology and pathogenesis of extrapyramidal movement disorders: a critical update-I. Hypokinetic-rigid movement disorders.

Authors:  Kurt A Jellinger
Journal:  J Neural Transm (Vienna)       Date:  2019-06-18       Impact factor: 3.575

6.  The Pentagon Copying Test and the Clock Drawing Test as Prognostic Markers in Dementia with Lewy Bodies.

Authors:  Leonie J M Vergouw; Mariet Salomé; Anke G Kerklaan; Christiaan Kies; Gerwin Roks; Esther van den Berg; Frank Jan de Jong
Journal:  Dement Geriatr Cogn Disord       Date:  2018-07-11       Impact factor: 2.959

Review 7.  Dementia with Lewy bodies - from scientific knowledge to clinical insights.

Authors:  Nikitas A Arnaoutoglou; John T O'Brien; Benjamin R Underwood
Journal:  Nat Rev Neurol       Date:  2019-02       Impact factor: 42.937

8.  Subtypes of dementia with Lewy bodies are associated with α-synuclein and tau distribution.

Authors:  Tanis J Ferman; Naoya Aoki; Bradley F Boeve; Jeremiah A Aakre; Kejal Kantarci; Jonathan Graff-Radford; Joseph E Parisi; Jay A Van Gerpen; Neill R Graff-Radford; Ryan J Uitti; Otto Pedraza; Melissa E Murray; Zbigniew K Wszolek; R Ross Reichard; Julie A Fields; Owen A Ross; David S Knopman; Ronald C Petersen; Dennis W Dickson
Journal:  Neurology       Date:  2020-06-19       Impact factor: 9.910

9.  Plasma and cerebrospinal fluid ABeta42 for the differential diagnosis of Alzheimer's disease dementia in participants diagnosed with any dementia subtype in a specialist care setting.

Authors:  Michelle Kokkinou; Lucy C Beishon; Nadja Smailagic; Anna H Noel-Storr; Chris Hyde; Obioha Ukoumunne; Rosemary E Worrall; Anja Hayen; Meera Desai; Abhishekh Hulegar Ashok; Eleanor J Paul; Aikaterini Georgopoulou; Tiziana Casoli; Terry J Quinn; Craig W Ritchie
Journal:  Cochrane Database Syst Rev       Date:  2021-02-10

10.  Sex differences for phenotype in pathologically defined dementia with Lewy bodies.

Authors:  Ece Bayram; David G Coughlin; Sarah J Banks; Irene Litvan
Journal:  J Neurol Neurosurg Psychiatry       Date:  2021-02-09       Impact factor: 10.154

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.